본문바로가기

About Production

Global Nutrition Solutions
Start Right Here.

GC Wellbeing’s Innovative Future

With the establishment of Eumseong Plant, a manufacturing site specialized in existing placenta preparations, Seongnam Plant, a manufacturing site for health supplements & foods, and the new Innovation Plant, GC Wellbeing is Solidifying its position as the supplier of safer and more effective pharmaceuticals and health supplements & foods.

Innovation Plant

Land Area 33,057㎡

Floor Area 18,512㎡

Annual production capacity of 27 million vials and 36 million ampules

  • 1. Multi-purpose Hall
    Function: Production, utilities, logistics & raw ingredient management, quality control, and quality assurance

    Production, logistics utilities, and quality management

    Includes refining room with Korea’s only placenta hydrolysis treatment equipment

    State-of-the-art GMP facilities required for production

    KGCSP warehouse—a pharmaceutical logistics space able to store 2,000 cells at room temperature and a height of 25m above the floor

  • 2. API Hall
    Function: Production of placental drugs and substances

    A place for recycling of placenta (classified as medical waste) to produce the raw ingredients needed

    Korea’s largest placental treatment facility with the best explosion-proof equipment for placental degreasing using acetone

  • 3. Administration Hall
    Function: Support operation of Innovation Plant

    Support office, conference rooms (large and small), auditorium, reception room, library, infirmary, cafeteria, a lounge for female employees, café, etc.

    Supporting Innovation Plant employees with five work support areas and five welfare areas

  • 4. Wastewater Treatment Facility
    Function: Waste and hazardous material storage (from Innovation Plant)

    Waste management facility with 200 tons per day treatment capacity.

    Treats wastewater from GC Wellbeing and GCMS

Eumseong Plant

A manufacturing site specialized in existing placenta preparations

A thorough virus test, Placenta history management, Clean collection and manufacturing system.

Report and approve DMF

Production of Laennec, a plancetal injection, and Fursultamine, GCVITAFIVE

Seongnam Plant

Manufacturing health supplements & foods

Research and development of individually-approved materials

KFDA’s FGMP certification acquired